Eikon Therapeutics
Founded Year
2019Stage
Series C | AliveTotal Raised
$665.8MLast Raised
$106M | 3 days agoAbout Eikon Therapeutics
Eikon Therapeutics operates as a biopharmaceutical company that specializes in drug discovery. The company's platform identifies compounds-protein interactions by measuring the effects of chemical compounds on the behavior of individual proteins in a live cellular environment. The company was founded in 2109 and is based in Hayward, California.
Missing: Eikon Therapeutics's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Eikon Therapeutics's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Eikon Therapeutics
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Eikon Therapeutics is included in 1 Expert Collection, including Unicorns- Billion Dollar Startups.
Unicorns- Billion Dollar Startups
1,215 items
Eikon Therapeutics Patents
Eikon Therapeutics has filed 1 patent.
The 3 most popular patent topics include:
- Biotechnology
- Cell imaging
- Fluorescent dyes
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
7/26/2022 | Application |
Application Date | 7/26/2022 |
|---|---|
Grant Date | |
Title | |
Related Topics | |
Status | Application |
Latest Eikon Therapeutics News
Jun 1, 2023
HAYWARD, Calif.--(BUSINESS WIRE)-- #Biotech--Eikon Therapeutics, Inc., a biotechnology company that is advancing breakthrough therapeutics through the purposeful integration of engineering and science, today announced it has acquired exclusive rights to multiple early- to mid-stage assets, leveraging its proprietary Single Molecule Tracking (SMT) technology to drive strategic decisions around its new drug pipeline. Eikon successfully completed three transactions, including the acquisition of global rights
Eikon Therapeutics Frequently Asked Questions (FAQ)
When was Eikon Therapeutics founded?
Eikon Therapeutics was founded in 2019.
Where is Eikon Therapeutics's headquarters?
Eikon Therapeutics's headquarters is located at 3929 Point Eden Way, Hayward.
What is Eikon Therapeutics's latest funding round?
Eikon Therapeutics's latest funding round is Series C.
How much did Eikon Therapeutics raise?
Eikon Therapeutics raised a total of $665.8M.
Who are the investors of Eikon Therapeutics?
Investors of Eikon Therapeutics include The Column Group, Foresite Capital, Lux Capital, Innovation Endeavors, General Catalyst and 15 more.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.